相关实验视频

Updated: Jun 23, 2025

A Method for Mouse Pancreatic Islet Isolation and Intracellular cAMP Determination

A Method for Mouse Pancreatic Islet Isolation and Intracellular cAMP Determination

Published on: June 25, 2014

选择性血清素再吸收抑制剂,塞特拉林和帕洛克塞丁,改善岛屿β细胞质量和功能在体外

Klaudia Toczyska¹, Naila Haq¹, Zekun Lyu¹

¹Department of Diabetes, School of Cardiovascular and Metabolic Medicine and Sciences, Faculty of Life Sciences & Medicine, King's College London, London, UK.

Diabetes, obesity & metabolism

|June 18, 2024

概括

选择性血清素再吸收抑制剂 (SSRI),如塞特拉林和帕洛克,可以增强β细胞的功能和质量. 这些发现表明,SSRI可能对2型糖尿病和抑郁症患者有益.

科学领域:

内分泌学在内分泌学.
药理学药理学是指药理学的学科.
细胞生物学细胞生物学

背景情况:

选择性血清素再吸收抑制剂 (SSRI) 通常用于治疗抑郁症.
对于SSRI对胰腺β细胞功能和质量的影响尚不完全理解.
了解这些影响对于管理患有同时存在抑郁症和糖尿病的患者至关重要.

研究的目的:

研究塞特拉林和帕洛克塞丁对β细胞质量和功能的影响.
为了确定SSRI的治疗度是否会影响胰岛素分泌,亡和扩散.
评估SSRI在2型糖尿病治疗中的潜力.

主要方法:

在MIN6细胞和小鼠群岛中,使用Trypan蓝色排除试验评估了β细胞活力.
胰岛素分泌量通过静态化和外周试验进行测量.
使用Caspase-Glo 3/7,TUNEL染色和BrdU整合等测试来评估亡和扩散.

主要成果:

治疗度的塞特拉林和帕罗克塞丁被β细胞耐受得很好,而较高度则是细胞毒性.
在小鼠和人类小岛上,SSRI显著增强了葡萄糖刺激的胰岛素分泌.
塞特拉林和帕洛克塞丁显示出对β细胞亡和β细胞增殖的保护作用.

结论:

塞特拉林和帕洛克塞丁通过改善胰岛素分泌,直接增强β细胞功能.
这些SSRI通过增加增殖和减少亡促进β细胞质量扩张.
研究结果表明,塞特拉林和帕洛克塞丁可能适用于治疗2型糖尿病患者的抑郁症.

关键词:

贝塔细胞的功能毒品机制药物机制胰岛素分泌的胰岛素分泌.小小的岛屿小小的岛屿 2 型糖尿病 2 型糖尿病

更多相关视频

Sustained Administration of β-cell Mitogens to Intact Mouse Islets Ex Vivo Using Biodegradable Poly(lactic-co-glycolic acid) Microspheres

Sustained Administration of β-cell Mitogens to Intact Mouse Islets Ex Vivo Using Biodegradable Poly(lactic-co-glycolic acid) Microspheres

Published on: November 5, 2016

A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform

A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform

Published on: July 16, 2016

相关概念视频

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...

Oral Hypoglycemic Agents: Biguanides and Glitazones

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...

Insulin Secretory Vesicles

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...